|
NEW YORK, Aug. 12, 2022 /PRNewswire/ --Hoth Therapeutics Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced today announced the company will be presenting at the Sidoti Investor Conference taking place on August 17-18, 2022.
To learn more about the Sidoti Investor Conference or register to attend visit https://www.sidoti.com/events
About Hoth Therapeutics, Inc.
Hoth Therapeutics is a clinical-stage biopharmaceutical company dedicated to develop innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life. We are a catalyst in early-stage pharmaceutical research and development, elevating drugs from the bench to pre-clinical and clinical testing. Utilizing a patient-centric approach, we collaborate and partner with a team of scientists, clinicians, and key opinion leaders to seek out and investigate therapeutics that hold immense potential to create breakthroughs and diversify treatment options. To learn more, please visit https://ir.hoththerapeutics.com/.
Investor Contact:
LR Advisors LLC
Email: investorrelations@hoththerapeutics.com
www.hoththerapeutics.com
Phone: (678) 570-6791
 View original content to download multimedia:https://www.prnewswire.com/news-releases/hoth-therapeutics-announces-pipeline-presentation-at-the-2022-sidoti-investor-conference-301605156.html
SOURCE Hoth Therapeutics, Inc.
|
